Mark T. Gladwin

Summarize Timeline Top Qs Fact Check

Gladwin earned a B.S. and M.D. (1991) through the 6-year B.S.-M.D. honors program in medical education at University of Miami .^[5] He completed an internal medicine internship and residency in 1994 and served as chief resident in 1995 at the Oregon Health & Science University.^[5] He was a critical care fellow at the National Institutes of Health Clinical Center in 1996.^[5] In 1998, he completed a fellowship in pulmonary critical care at the University of Washington.^[5] He returned to the NIH Clinical Center as a senior research fellow in critical care medicine until 2000, also serving as the Chief of the Pulmonary and Vascular Medicine Branch of the National Heart, Lung, and Blood Institute.^[6][5]

Gladwin joined the University of Pittsburgh School of Medicine in 2008 as a professor and Division Chief of Pulmonary, Allergy and Critical Care Medicine, and also served as the inaugural director of the University’s Vascular Medicine Institute.^[7][8] In 2015, he was appointed chair of the department of medicine.^[9] By the time Gladwin left the university in 2022, the department employed more than 1,000 faculty and had combined clinical and research revenues of almost $600 million.^[9][10]

On August 1, 2022, Gladwin was appointed dean of the University of Maryland School of Medicine,^[5][1] succeeding longtime dean E. Albert Reece.^[8] He oversees 46 academic departments with a total annual operating budget of $1.3 billion and more than 7,000 faculty, trainees, students and staff.^[11]

Since becoming dean, Gladwin has helped launched new institutes and initiatives focusing on addiction medicine, health computing/ AI, neuroscience, bioengineering, new venture formation, and community health^[12].

The Kahlert Institute for Addiction Medicine, within the school of medicine, focuses on understanding the underpinnings of addiction, uncovering new approaches to the treatment of opioid use disorder, bringing together neuroscientists studying the brain mechanisms underlying addictions and physician educators working to train a new generation of medical students and residents^[13][14]. The medical school’s Medicine Institute for Neuroscience Discovery (UM-MIND) focuses on  neurodevelopment and neuropsychiatric disorders, neurotrauma and brain injury, as well as aging and neurodegeneration.^[15][16].

To consolidate and amplify the school of medicine’s global footprint in clinical care, research and education, Gladwin formed the Global Health Alliance focusing on improving health outcomes in developing countries through research collaborations and capacity building^[17].

Gladwin was also involved in establishing the University of Maryland Institute for Health Computing (UM-IHC), located in North Bethesda, Maryland, which applies artificial intelligence and bioinformatics techniques to health data to support drug discovery, population health, and other computationally intensive research areas. He noted that he sees this part of Maryland “becoming the East Coast Silicon Valley of health computing^[18][19].

Gladwin’s other major initiatives for the school of medicine include addressing the doctor shortage in Maryland^[20]. He established the Rural-MD Scholars Program, which trains medical students in caring for patients in Maryland’s Eastern Shore region and aims to reduce the shortage of clinicians in rural practice. He also helped establish the Edward & Jennifer St. John Center for Translational Engineering and Medicine, which brings together engineering and clinical faculty to research bioengineering solutions to medical challenges^[21].

In 2025, Gladwin, along with other leaders from the University of Maryland, Baltimore, and the University of Maryland Medical System, announced the receipt of a $50 million donation from billionaire philanthropist Tom Golisano. The donation, the largest in the institution’s history, will fund renovations to what is now known as the University of Maryland Golisano Children’s Hospital, within the University of Maryland Medical Center^[22][23].

Gladwin has also recruited new leadership in multiple academic departments, including internationally recognized inflammatory skin disorder expert Shawn Kwatra to chair the department of dermatology and leading pulmonologist Roberto Machado to chair the school’s department of medicine^[24][25][26] Gladwin also recruited leading neuroanesthesiology expert David Mintz to chair the department of anesthesiology, maternal health researcher Andreea Creanga to chair the department of epidemiology and public health, Tarek Hanna, an expert in emergency and trauma radiology, as chair of the department of diagnostic radiology and nuclear medicine^[27][28][29], and Irina Burd, the Sylvan Frieman, MD Endowed Professor, as Chair of the Department of Obstetrics, Gynecology & Reproductive Science^[30]. He hired new leaders for the school’s research institutes, such as Elana Fertig to take the helm of the Institute for Genome Sciences, malaria vaccine researcher Stefan Kappe to direct the school’s Center for Vaccine Development and Global Health, and Bradley A. Maron to co-direct the Institute for Health Computing^{[31][32][33][34][35]}.

Gladwin is co-author of two medical textbooks in the "Made Ridiculously Simple" series from publisher Medmaster Inc. He wrote Clinical Microbiology Made Ridiculously Simple with physicians William Trattler and C. Scott Mahan, and Critical Care and Hospitalist Medicine Made Ridiculously Simple with physician Michael Donahoe.^[36][37]